Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients

  title={Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients},
  author={Stephanie L. Siehr and Elisa K. McCarthy and Michelle T. Ogawa and Jeffrey Allan Feinstein},
  booktitle={Front. Pediatr.},
BACKGROUND Sildenafil, a phosphodiestase type 5 inhibitor, was approved in 2005 for the treatment of pulmonary arterial hypertension (PAH) in adults and is commonly used off-label for pediatric patients. Little is known, however, about sildenafil's side effects in this population. METHODS Single institution, longitudinal survey-based study performed in an outpatient pediatric cardiology clinic. Pediatric patients on sildenafil [alone or in combination with other pulmonary hypertension (PH… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications referenced by this paper.
Showing 1-9 of 9 references

Similar Papers

Loading similar papers…